![Claire Untereiner](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Claire Untereiner served as the Chief Operating Officer at PX Therapeutics SA from 2008 to 2018.
She is a graduate of EM Lyon Business School and the University of Lyon.
Anciens postes connus de Claire Untereiner
Sociétés | Poste | Fin |
---|---|---|
PX Therapeutics SA
![]() PX Therapeutics SA Miscellaneous Commercial ServicesCommercial Services PX Therapeutics SA manufactures and develops recombinant proteins and monoclonal antibodies. Its services include protein engineering, optimization of drug candidates, humanization of antibodies, and production and release of GMP batches for clinical studies. The firm specializes in the field of in-vivo and in-vitro diagnostics, industrial enzymes, and ancillary products. The company was founded by Tristan Rousselle and Nicolas Mouz in November 2000 and is headquartered in Grenoble, France. | Directeur des opérations | 01/06/2018 |
Formation de Claire Untereiner
University of Lyon | Graduate Degree |
EM Lyon Business School | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
PX Therapeutics SA
![]() PX Therapeutics SA Miscellaneous Commercial ServicesCommercial Services PX Therapeutics SA manufactures and develops recombinant proteins and monoclonal antibodies. Its services include protein engineering, optimization of drug candidates, humanization of antibodies, and production and release of GMP batches for clinical studies. The firm specializes in the field of in-vivo and in-vitro diagnostics, industrial enzymes, and ancillary products. The company was founded by Tristan Rousselle and Nicolas Mouz in November 2000 and is headquartered in Grenoble, France. | Commercial Services |